← SynDRA
BGT-226 FREE BASE
SynDRA canonical compound SYN0037984 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
|---|
| Primary target(s) | MTOR | PIK3CA | PIK3CB | PIK3CG |
|---|
| Mechanism of action | PI3K inhibitor |
|---|
All known targets
- MTOR
- PIK3CG
- PIK3CA
- PIK3CB
Mechanisms of action (all sources)
- MTOR inhibitor
- Serine/threonine-protein kinase mTOR inhibitor
- PIK3CA INHIBITOR
- PIK3CB INHIBITOR
- PIK3CG INHIBITOR
- PI3K inhibitor
- MTOR MODULATOR
- PIK3CG MODULATOR
Cross-references
Synonyms
- BGT-226
- BGT226 free base
- BGT 226
- ZXE7F2GMJJ
- UNII-ZXE7F2GMJJ
- C28H25F3N6O2
- BGT-226 (maleate salt)
- NPV-BGT226
- SCHEMBL146939
- GTPL7951
- orb1301099
- SCHEMBL29351405
- SCHEMBL29388241
- SCHEMBL29388607
- CHEBI:71967
- BMMXYEBLEBULND-UHFFFAOYSA-N
- BDBM185147
- EX-A3430
- HY-13334A
- MFCD22376639
- NSC773095
- NSC799358
- T6072L
- AKOS037643410
- EBC-428047
- NSC-773095
- NSC-799358
- SDCCGSBI-0654465.P001
- NCGC00346681-01
- NCGC00346681-09
- NCGC00346681-10
- NCGC00346681-11
- NCGC00346681-13
- AS-16313
- DA-18144
- US9284315, BGT-226
- CS-0034414
- G14161
Look up BGT-226 FREE BASE in the interactive SynDRA portal →